We are live on
!
Find out more
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
24 hedge funds and large institutions have $14.8M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
19% less capital invested
Capital invested by funds: $18.3M → $14.8M (-$3.47M)
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Holders
24
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$230K | |
| 2 | +$216K | |
| 3 | +$189K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$47.6K |
| 5 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$45.3K |
Top Sellers
| 1 | -$1.5M | |
| 2 | -$755K | |
| 3 | -$477K | |
| 4 |
Citigroup
New York
|
-$107K |
| 5 |
LPL Financial
San Diego,
California
|
-$70.1K |